A biomarker for early diagnosis or prediction of complications of acute pancreatitis infection
CN119335169BActive Publication Date: 2026-06-19RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
- Filing Date
- 2024-09-12
- Publication Date
- 2026-06-19
Smart Images
Figure CN119335169B_ABST
Abstract
This invention relates to a biomarker for the early diagnosis or prediction of infectious complications of acute pancreatitis. The invention evaluated the predictive ability of plasma KA (kavaginal acetate) for the occurrence of IPN in patients with acute pancreatitis. The results showed that the AUC of KA in predicting IPN in the validation set of patients reached 0.805, exceeding the AUC of APACHE II and IL-10. These results indicate that plasma KA can serve as a highly effective biomarker for the early prediction of IPN in patients with acute pancreatitis.
Need to check novelty before this filing date? Find Prior Art